Why is palpable purpura a type III hypersensitivity reaction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Palpable purpura is a type III hypersensitivity reaction due to immune complex deposition in small blood vessels, as evidenced by the Gell and Coombs classification of hypersensitivity reactions 1. This classification system categorizes hypersensitivity reactions into four types, with type III being characterized by immune complex-mediated hypersensitivity, which includes conditions such as serum sickness, vasculitis, and palpable purpura.

Key Characteristics of Type III Hypersensitivity

  • Immune complex deposition in vessel walls
  • Activation of complement and attraction of neutrophils
  • Release of inflammatory mediators and enzymes that damage vessel walls
  • Leakage of red blood cells into surrounding tissues, resulting in palpable purpura Some common conditions associated with type III hypersensitivity reactions include:
  • Leukocytoclastic vasculitis
  • Henoch-Schönlein purpura
  • Serum sickness As noted in a recent guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis, palpable purpura is a vasculitis-specific lesion that can occur in this condition 1.

Diagnosis and Treatment

The diagnosis of palpable purpura is typically confirmed by skin biopsy, which shows immune complex deposition, neutrophilic infiltration, and fibrinoid necrosis of vessel walls. Treatment depends on the underlying cause, but may include:

  • Removing the triggering antigen
  • Administering corticosteroids to reduce inflammation
  • Using immunosuppressive agents in severe or persistent cases It is essential to prioritize the most recent and highest-quality evidence when making clinical decisions, and in this case, the Gell and Coombs classification of hypersensitivity reactions provides a clear framework for understanding the pathophysiology of palpable purpura 1.

From the Research

Hypersensitivity Reactions

  • Hypersensitivity reactions are categorized into four subtypes according to the type of immune response and the effector mechanism responsible for cell and tissue injury 2
  • Type III hypersensitivity reactions are characterized by IgG/IgM immune complex mediated responses 2, 3

Palpable Purpura

  • Palpable purpura is a hallmark of cutaneous vasculitis, which is often associated with immune complex formation and vessel damage 4
  • The pathogenic mechanisms of palpable purpura appear to be complex, involving immune complex formation, vessel damage, and altered vessel function mediated by infectious agents or immunologic responses 4
  • Cutaneous vasculitis, secondary to drug reaction, infection, or collagen vascular disease, is a common identifiable cause of palpable purpura 5

Type III Hypersensitivity and Palpable Purpura

  • Given that palpable purpura involves immune complex formation, it can be classified as a type III hypersensitivity reaction 2, 3
  • The immune complex mediated response in type III hypersensitivity reactions is consistent with the pathogenic mechanisms of palpable purpura 4, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Chapter 28: Classification of hypersensitivity reactions.

Allergy and asthma proceedings, 2012

Research

Classification of hypersensitivity reactions.

Allergy and asthma proceedings, 2019

Research

[Infection and vascular purpura].

Journal des maladies vasculaires, 1999

Research

Palpable purpura: an algorithmic approach.

American family physician, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.